nodes	percent_of_prediction	percent_of_DWPC	metapath
Pefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—KRT14—esophageal cancer	0.0445	0.0481	CbGpPWpGaD
Pefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—RUNX1—esophageal cancer	0.0363	0.0392	CbGpPWpGaD
Pefloxacin—CYP1A2—Sulindac Metabolic Pathway—CYP1B1—esophageal cancer	0.028	0.0302	CbGpPWpGaD
Pefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—SFN—esophageal cancer	0.0248	0.0268	CbGpPWpGaD
Pefloxacin—Lomefloxacin—ABCC2—esophageal cancer	0.0236	0.317	CrCbGaD
Pefloxacin—CYP1A2—Fatty Acid Omega Oxidation—ADH7—esophageal cancer	0.0236	0.0255	CbGpPWpGaD
Pefloxacin—CYP1A2—Tryptophan metabolism—ALDH3A2—esophageal cancer	0.0207	0.0224	CbGpPWpGaD
Pefloxacin—CYP1A2—Fatty Acid Omega Oxidation—ADH1B—esophageal cancer	0.0207	0.0223	CbGpPWpGaD
Pefloxacin—Ofloxacin—ABCC2—esophageal cancer	0.0201	0.271	CrCbGaD
Pefloxacin—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—esophageal cancer	0.0192	0.0208	CbGpPWpGaD
Pefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—FBXW7—esophageal cancer	0.0191	0.0206	CbGpPWpGaD
Pefloxacin—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—esophageal cancer	0.0175	0.0189	CbGpPWpGaD
Pefloxacin—Norfloxacin—CYP2A6—esophageal cancer	0.0161	0.217	CrCbGaD
Pefloxacin—TOP2A—Gastric Cancer Network 1—NOTCH1—esophageal cancer	0.0158	0.0171	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—ALDH3A1—esophageal cancer	0.0157	0.017	CbGpPWpGaD
Pefloxacin—CYP1A2—Fatty Acid Omega Oxidation—ALDH2—esophageal cancer	0.0146	0.0157	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—CRTC1—esophageal cancer	0.0139	0.015	CbGpPWpGaD
Pefloxacin—CYP1A2—Fatty Acid Omega Oxidation—CYP2A6—esophageal cancer	0.0137	0.0148	CbGpPWpGaD
Pefloxacin—CYP1A2—Estrogen Receptor Pathway—CYP1B1—esophageal cancer	0.013	0.0141	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FKBP1A—esophageal cancer	0.0126	0.0136	CbGpPWpGaD
Pefloxacin—CYP1A2—Xenobiotics—CYP2A6—esophageal cancer	0.0114	0.0124	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—HMGB1—esophageal cancer	0.0111	0.012	CbGpPWpGaD
Pefloxacin—CYP1A2—Tamoxifen metabolism—CYP2A6—esophageal cancer	0.011	0.0119	CbGpPWpGaD
Pefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—esophageal cancer	0.0108	0.0116	CbGpPWpGaD
Pefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—esophageal cancer	0.0105	0.0114	CbGpPWpGaD
Pefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—esophageal cancer	0.0105	0.0114	CbGpPWpGaD
Pefloxacin—CYP1A2—Estrogen metabolism—CYP1B1—esophageal cancer	0.01	0.0108	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BBC3—esophageal cancer	0.0098	0.0106	CbGpPWpGaD
Pefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—esophageal cancer	0.00937	0.0101	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—ABL1—esophageal cancer	0.00921	0.00995	CbGpPWpGaD
Pefloxacin—CYP1A2—Tamoxifen metabolism—CYP1B1—esophageal cancer	0.00888	0.00959	CbGpPWpGaD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—PSME2—esophageal cancer	0.00883	0.00954	CbGpPWpGaD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—PSME1—esophageal cancer	0.00883	0.00954	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—AJUBA—esophageal cancer	0.00871	0.00941	CbGpPWpGaD
Pefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—esophageal cancer	0.00854	0.00923	CbGpPWpGaD
Pefloxacin—TOP2A—Gastric Cancer Network 2—MYC—esophageal cancer	0.00808	0.00873	CbGpPWpGaD
Pefloxacin—TOP2A—Gastric Cancer Network 2—EGFR—esophageal cancer	0.0079	0.00854	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—AJUBA—esophageal cancer	0.00779	0.00841	CbGpPWpGaD
Pefloxacin—CYP1A2—Arachidonic acid metabolism—ALOX15—esophageal cancer	0.00752	0.00813	CbGpPWpGaD
Pefloxacin—Levofloxacin—ABCB1—esophageal cancer	0.00741	0.0996	CrCbGaD
Pefloxacin—Ciprofloxacin—ABCB1—esophageal cancer	0.00716	0.0962	CrCbGaD
Pefloxacin—TOP2A—Cell Cycle—MLH3—esophageal cancer	0.00704	0.00761	CbGpPWpGaD
Pefloxacin—CYP1A2—Melatonin metabolism and effects—CYP1B1—esophageal cancer	0.00686	0.00741	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—NFE2L2—esophageal cancer	0.00684	0.00739	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NFE2L2—esophageal cancer	0.00684	0.00739	CbGpPWpGaD
Pefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.00667	0.00721	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ANXA1—esophageal cancer	0.00666	0.00719	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.00664	0.00717	CbGpPWpGaD
Pefloxacin—TOP2A—Gastric Cancer Network 2—TP53—esophageal cancer	0.00663	0.00717	CbGpPWpGaD
Pefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.00658	0.00711	CbGpPWpGaD
Pefloxacin—CYP1A2—Tryptophan metabolism—ALDH2—esophageal cancer	0.00625	0.00676	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	0.00609	0.00658	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—GHRL—esophageal cancer	0.00606	0.00655	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RB1—esophageal cancer	0.00594	0.00642	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.00582	0.00629	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	0.00579	0.00626	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.00541	0.00584	CbGpPWpGaD
Pefloxacin—CYP1A2—Arachidonic acid metabolism—PTGS1—esophageal cancer	0.00521	0.00563	CbGpPWpGaD
Pefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.00497	0.00537	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	0.00491	0.0053	CbGpPWpGaD
Pefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.00475	0.00514	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	0.00475	0.00514	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—esophageal cancer	0.00475	0.00514	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—esophageal cancer	0.00474	0.00512	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—esophageal cancer	0.00474	0.00512	CbGpPWpGaD
Pefloxacin—CYP1A2—Tryptophan metabolism—CYP1B1—esophageal cancer	0.00474	0.00512	CbGpPWpGaD
Pefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.00469	0.00507	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—GSTO1—esophageal cancer	0.00457	0.00493	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	0.0045	0.00486	CbGpPWpGaD
Pefloxacin—CYP1A2—Tryptophan metabolism—CYP19A1—esophageal cancer	0.00446	0.00482	CbGpPWpGaD
Pefloxacin—CYP1A2—Arachidonic acid metabolism—CYP1B1—esophageal cancer	0.00443	0.00479	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—esophageal cancer	0.00441	0.00476	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—esophageal cancer	0.00427	0.00461	CbGpPWpGaD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—RB1—esophageal cancer	0.00418	0.00451	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—HIST1H2BM—esophageal cancer	0.00418	0.00451	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.0041	0.00443	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.00385	0.00416	CbGpPWpGaD
Pefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.00383	0.00414	CbGpPWpGaD
Pefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.00378	0.00409	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—HIST1H2BM—esophageal cancer	0.00373	0.00403	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—esophageal cancer	0.00369	0.00399	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—MAD2L1—esophageal cancer	0.00369	0.00398	CbGpPWpGaD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—esophageal cancer	0.00367	0.00397	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.00365	0.00395	CbGpPWpGaD
Pefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.0036	0.00389	CbGpPWpGaD
Pefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.00356	0.00384	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—GSTT1—esophageal cancer	0.00354	0.00383	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—esophageal cancer	0.00354	0.00382	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—ADH7—esophageal cancer	0.00352	0.00381	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—NOS2—esophageal cancer	0.0034	0.00367	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—MAD2L1—esophageal cancer	0.0033	0.00356	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—PSME1—esophageal cancer	0.00324	0.0035	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—PSME2—esophageal cancer	0.00324	0.0035	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	0.00319	0.00345	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	0.00318	0.00343	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.00311	0.00336	CbGpPWpGaD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—esophageal cancer	0.0031	0.00335	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—ADH1B—esophageal cancer	0.00309	0.00334	CbGpPWpGaD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1A—esophageal cancer	0.003	0.00324	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—BUB1B—esophageal cancer	0.00295	0.00319	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.00292	0.00316	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—esophageal cancer	0.00291	0.00314	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—PSME1—esophageal cancer	0.0029	0.00313	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—PSME2—esophageal cancer	0.0029	0.00313	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—CYP26A1—esophageal cancer	0.00287	0.0031	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—CYP26A1—esophageal cancer	0.00283	0.00306	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	0.00274	0.00296	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—GSTO1—esophageal cancer	0.00267	0.00289	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	0.00266	0.00288	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—BUB1B—esophageal cancer	0.00264	0.00285	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—GSTO1—esophageal cancer	0.00263	0.00285	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	0.0026	0.00281	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—esophageal cancer	0.0026	0.00281	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CHEK2—esophageal cancer	0.00251	0.00271	CbGpPWpGaD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—esophageal cancer	0.00249	0.00269	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	0.00235	0.00254	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	0.00227	0.00246	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—ALDH2—esophageal cancer	0.00218	0.00235	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	0.00216	0.00234	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—esophageal cancer	0.00214	0.00231	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—EP300—esophageal cancer	0.00208	0.00224	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—GSTT1—esophageal cancer	0.00207	0.00224	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—CYP2A6—esophageal cancer	0.00205	0.00221	CbGpPWpGaD
Pefloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.002	0.00216	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—PTGS1—esophageal cancer	0.00194	0.0021	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	0.00189	0.00204	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—esophageal cancer	0.00187	0.00202	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	0.00184	0.00199	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—esophageal cancer	0.00178	0.00192	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—esophageal cancer	0.00178	0.00192	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—CYP1B1—esophageal cancer	0.00165	0.00178	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—CYP1B1—esophageal cancer	0.00163	0.00176	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	0.0016	0.00173	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.00159	0.00172	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—CYP19A1—esophageal cancer	0.00155	0.00168	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	0.00155	0.00167	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	0.00155	0.00167	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—RB1—esophageal cancer	0.00153	0.00166	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—CYP19A1—esophageal cancer	0.00153	0.00165	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—esophageal cancer	0.00151	0.00164	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	0.00151	0.00164	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—TP53—esophageal cancer	0.00149	0.00161	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—RB1—esophageal cancer	0.00137	0.00148	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—esophageal cancer	0.00135	0.00146	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CDKN2A—esophageal cancer	0.0012	0.0013	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—esophageal cancer	0.00114	0.00123	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—esophageal cancer	0.0011	0.00119	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.00108	0.00116	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—EP300—esophageal cancer	0.00105	0.00113	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CCND1—esophageal cancer	0.00102	0.0011	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CDKN1A—esophageal cancer	0.000984	0.00106	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000938	0.00101	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—EP300—esophageal cancer	0.000937	0.00101	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—MYC—esophageal cancer	0.000913	0.000986	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—BLVRB—esophageal cancer	0.000834	0.000901	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—SLC52A3—esophageal cancer	0.000834	0.000901	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—MYC—esophageal cancer	0.000816	0.000882	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000745	0.000805	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—SLC10A2—esophageal cancer	0.000709	0.000766	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CA1—esophageal cancer	0.000709	0.000766	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—TP53—esophageal cancer	0.00067	0.000724	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CA2—esophageal cancer	0.000648	0.000701	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000634	0.000685	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ADH7—esophageal cancer	0.000603	0.000651	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PLCE1—esophageal cancer	0.000603	0.000651	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000596	0.000644	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ADH1B—esophageal cancer	0.000529	0.000571	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—TYMP—esophageal cancer	0.000505	0.000546	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CYP26A1—esophageal cancer	0.000491	0.000531	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ALOX15—esophageal cancer	0.000479	0.000517	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—TPI1—esophageal cancer	0.000457	0.000494	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTO1—esophageal cancer	0.000457	0.000494	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ALDOB—esophageal cancer	0.000438	0.000473	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GAPDH—esophageal cancer	0.000422	0.000455	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CRABP1—esophageal cancer	0.000418	0.000451	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GNG7—esophageal cancer	0.000397	0.000429	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ALDH2—esophageal cancer	0.000372	0.000402	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTT1—esophageal cancer	0.000354	0.000383	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CYP2A6—esophageal cancer	0.00035	0.000378	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000349	0.000377	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PTGS1—esophageal cancer	0.000332	0.000359	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ENO1—esophageal cancer	0.000332	0.000359	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PSME2—esophageal cancer	0.000327	0.000353	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PSME1—esophageal cancer	0.000327	0.000353	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000286	0.000309	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CYP1B1—esophageal cancer	0.000282	0.000305	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CYP19A1—esophageal cancer	0.000265	0.000287	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—HMOX1—esophageal cancer	0.000242	0.000262	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.000238	0.000257	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ABCB1—esophageal cancer	0.000232	0.000251	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	0.000176	0.00019	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CREBBP—esophageal cancer	0.000155	0.000168	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—NOS3—esophageal cancer	0.000139	0.00015	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PTGS2—esophageal cancer	0.000127	0.000137	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—EP300—esophageal cancer	0.000106	0.000114	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PIK3CA—esophageal cancer	7.83e-05	8.46e-05	CbGpPWpGaD
